引導式測驗 · 中等 等級
AI 胜肽治療設計測驗
測試計算設計與治療證據、結合和功能、穩定性、選擇性和實驗驗證。
問題 1 的 8
What does a computationally designed peptide sequence establish?
預覽每個問題8 問題
當您參加測驗時,就會出現答案和解釋。
- What does a computationally designed peptide sequence establish?
- Proof of target engagement in the body
- A candidate sequence for experimental testing
- A clinically effective medicine
- A safe dose for patients
- Why test binding with an independent assay?
- A predicted interface may not reflect actual experimental binding
- A structural model proves binding already
- Independent assays replace biological controls
- Binding results determine clinical efficacy
- Does a peptide binder necessarily alter target function?
- Yes, all binders inhibit targets
- Yes, docking scores measure function
- No, peptides cannot bind proteins
- No; binding alone does not show agonism, inhibition, or therapeutic effect
- Which properties should be checked beyond target binding?
- Only model confidence
- Only the target’s name
- Stability, selectivity, delivery, exposure, and toxicity
- Only sequence length
- Why might a peptide fail despite a strong predicted structure?
- The model tested toxicity already
- Its experimental conformation or biological stability may differ
- Predicted structure guarantees in-vivo exposure
- A flexible target always binds tightly
- Which evidence is needed before describing a candidate as a therapy?
- One in-vitro binding result
- A generated amino-acid sequence
- Evidence progresses through functional, safety, pharmacology, and clinical studies
- A docking score above a threshold
- What information supports reproducibility of peptide experiments?
- Sequence, modifications, target construct, assay conditions, and model version
- Only the project title
- Only the lab’s location
- Only the predicted structure image
- What can AI contribute to peptide development?
- Replace synthesis and safety studies
- Guarantee delivery to a tissue
- Confirm patient benefit from binding
- Prioritize sequences and explore a design space for later testing